In this prospective study of critically ill COVID-19 patients, the lymphocyte expression levels of CD markers for the examined T cell subsets (CD2, CD4, CD8, CD158d, and CD25) and CD127 as well as CD19 were lower in COVID-19 patients than in HCs. The gene discussed is CD2; the disease is COVID-19.